The Relationship of Serum Alpha-Interferon and Ultrastructural Markers in HIV-Seropositive Individuals

References

• Abbott S R, Buimovici-Klein E, Cooper L Z, Lange M, Briggs M, Weller I VD. Rapid detection of immunoreactive interferon-α in AIDS. Lancet 1984; i: 564
   Google Scholar
• Buimovici-Klein E, Lange M, Klein R J, Cooper L Z, Grieco M H. Is presence of interferon predictive for AIDS?. Lancet 1983; ii: 344
   Google Scholar
• Eyster M E, Goedert J J, Poon M-C, Preble O T. Acid-labile alpha interferon. A possible preclinical marker for the acquired immunodeficiency syndrome in hemophilia. N Engl J Med 1983; 309: 583–586
   PubMed Web of Science ®Google Scholar
• DeStefano E, Friedman R M, Friedman-Kien A E, et al. Acid-labile human leukocyte interferon in homosexual men with Kaposi's sarcoma and lymphadenopathy. J Infect Dis 1982; 146: 451–455
   PubMed Web of Science ®Google Scholar
• Buimovici-Klein E, Lange M, Klein R J, Grieco M H, Cooper L Z. Long-term follow-up of serum-interferon and its acid-stability in a group of homosexual men. AIDS RES 1986; 2: 99–108
   PubMedGoogle Scholar
• Huygen K, Mascart-Lemone F, Cran S, et al. Analysis of the interferon system in African patients with acquired immunodeficiency syndrome. Eur J Clin Microbiol 1985; 4: 304–309
   PubMedGoogle Scholar
• Lopez C, Fitzgerald P A, Siegal F P. Severe acquired immune deficiency syndrome in male homosexuals: Diminished capacity to make interferon-α in vitro associated with severe opportunistic infections. J Infect Dis 1983; 148: 962–966
   PubMed Web of Science ®Google Scholar
• Murray H W, Hillman J K, Rubin B Y, et al. Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. N Engl J Med 1985; 313: 1504–1510
   PubMed Web of Science ®Google Scholar
• Murray H W, Welte K, Jacobs J L, Rubin B Y, Mertelsmann R, Roberts R B. Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. J Clin Invest 1985; 76: 1959–1964
   PubMed Web of Science ®Google Scholar
• Read S E, Williams B RG, Coates R A, et al. Elevated levels of interferon-induced 2′,5′-oligoadenylate synthetase in generalized persistent lymphadenopathy and the Acquired Immunodeficiency Syndrome. J Infect Dis 1985; 152: 466–472
   PubMedGoogle Scholar
• Grimley P M, Kang Y-H, Frederick W, et al. Interferon-related leukocyte inclusions in acquired immune deficiency syndrome: Localization in T cells. Am J Clin Pathol 1984; 81: 147–155
   PubMed Web of Science ®Google Scholar
• Sidhu G S, Stahl R E, El-Sadr W, Cassai N D, Forrester E M, Zollar-Pazner S. The acquired immunodeficiency syndrome: An ultrastructural study. Hum Pathol 1985; 16: 377–386
   PubMed Web of Science ®Google Scholar
• Orentstein J M, Simon G L, Kessler C M, Schulof R S. Ultrastructural markers in circulating lymphocytes of subjects at risk for AIDS. Am J Clin Pathol 1985; 84: 603–609
   PubMedGoogle Scholar
• Rich S A. Human lupus inclusions and interferon. Science 1981; 213: 772–775
   PubMed Web of Science ®Google Scholar
• Bockus D, Remington F, Luu J, Friedman S, Bean M, Hammar S. Induction of cylindrical confronting cisternae (CCC) in Daudi lymphoblastoid cells by recombinant α-interferon (rα-IFN). Lab Invest 1986; 54: 7A
   Google Scholar
• Grimley P M, Kang Y-H, Masur H, . Tubuloreticular inclusions in patients with AIDS: Interferon-related effect in circulating T-cells and monocytes. AIDS: The Epidemic of Kaposi's Sarcoma and Opportunistic Infections, A E Friedman-Kein, L J Laubenstein, et al. Masson, New York 1984; 181–192
   Google Scholar
• Grimely P M, Rutherford M N, Kang Y-H, Williams T, Woody J N, Silverman R H. Formation of tubuloreticular inclusions in human lymphoma cells compared to the induction of 2′, 5′-oligoadenylate synthetatase by leukocyte interferon in dose-effect and kinetic studies. Cancer Res 1984; 144: 3480–3488
   Google Scholar
• Grimley P M, Davis G L, Kang Y-H, Dooley J S, Strohmaier J, Hoofnagle J H. Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with α-interferon. Lab Invest 1985; 52: 638–649
   PubMed Web of Science ®Google Scholar
• Preble O T, Black R J, Friedman R M, Klippel J H, Vilcek J. Systemic lupus erythematosus presence in human serum of an unusual acid-labile leukocyte interferon. Science 1982; 216: 429–431
   PubMed Web of Science ®Google Scholar
• Donahoe R M, Huang K-Y. Interferon preparations enhance phagocytosis in vivo. Infect Immun 1976; 13: 1250–1257
   PubMedGoogle Scholar
• Kostianovsky M, Kang Y-H, Grimley P M. Ultrastructural and immunoelectron microscopic studies of cells with abnormal cytoplasmic inclusions in patients with AIDS. AIDS Res 1984; 1: 181–196
   Google Scholar
• Preble O T, Friedman R M. Interferon-induced alterations in cells: Relevance to viral and non-viral diseases. Lab Invest 1983; 49: 4–18
   PubMed Web of Science ®Google Scholar
• Preble O T, Rook A H, Steis R, et al. Interferoninduced 2′,5′-oligoadenylate synthetase during interferon-α therapy in homosexual men with Kaposi's sarcoma: Marked deficiency in biochemical response in interferon in patients with Acquired Immunodeficiency Syndrome. J Infect Dis 1985; 152: 457–465
   PubMedGoogle Scholar
• Schattner A, Merlin G, Shapira A, Revel M, Wallach D. Comparison of (2′,5′) oligoadenylate synthetase and interferon blood levels in mice early after viral infection. J Interferon Res 1982; 2: 285–289
   PubMedGoogle Scholar
• Preble O T, Rothko K R, Klippel J H, Friedman R M, Johnston M I. Interferon-induced 2′, 5′-adenylate synthetase in vivo and interferon production in vitro by lymphocytes from systemic lupus erythematosus patients with and without circulating interferon. J Exp Med 1983; 157: 2140–2146
   PubMedGoogle Scholar
• LeTourneau A, Audouin J, Diebold J, Marche C, Tricottet V, Reynes M. LAV-like viral particles in lymph node germinal centers in patients with the persistent lymphadenopathy syndrome and the acquired immunodeficiency syndrome-related complex: An ultrastructural study of 30 cases. Hum Pathol 1986; 17: 1047–1053
   PubMedGoogle Scholar
• Rich S A, Owens T R, Bartholomew L E, Gutterman J U. Immune interferon does not stimulate formation of alpha and beta interferon induced human lupus-type inclusions. Lancet 1983; i: 127–128
   Google Scholar